by Prostate Cancer Center | Jan 3, 2018 | Prostate Cancer
BY Ash Tewari, Md, New York Daily News Options for treating prostate cancer have improved dramatically in recent years. We still have to battle the disease, but most of the time, we win. Over the course of a lifetime, about one in seven men will develop prostate...
by Prostate Cancer Center | Jan 3, 2018 | Prostate Cancer
Since 2011, Howard Maharaj had an elevated PSA score but was reluctant to go to a doctor to have his prostate checked. “I was in denial, said Howard.” It wasn’t until 5 years later in January of 2016 while experiencing frequent urination that woke him 2 –3 times a...
by Prostate Cancer Center | Jan 2, 2018 | Prostate Cancer
CyberKnife Radiation Therapy is becoming the Treatment Choice for Prostate Cancer for many reasons: 1. It’s the only treatment form in which the radiation beam moves with the patient as he breathes so it can deliver a higher more precise dose. 2. Because the...
by Prostate Cancer Center | Jan 2, 2018 | Prostate Cancer
Accuray Incorporated (NASDAQ: ARAY) announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent had local disease control 10 years after receiving stereotactic body radiation therapy (SBRT) administered with the...
by Prostate Cancer Center | Dec 28, 2017 | Prostate Cancer
A recent study from Brigham and Women’s Hospital and Harvard Chan School of Public Health found that mid-life prostate-specific antigen (PSA) levels predict who will be more likely to develop lethal prostate cancer. PSA screening tests have helped doctors to diagnosis...
by Prostate Cancer Center | Dec 28, 2017 | Prostate Cancer
It takes a village to handle and survive metastatic prostate cancer, a prostate cancer that has spread to bones or lungs or lymph nodes and elsewhere. And one of the crucial aspects of that village, for me, has been the CyberKnife, a form of radiation that has been...
Recent Comments